The use of oral terbinafine (Lamisil(R)) in children

被引:10
|
作者
Krafchik, B
Pelletier, J
机构
[1] Department of Dermatology, Hospital for Sick Children, Toronto
关键词
griseofulvin; tinea capitis; tolerability; children; Trichophyton; Microsporum; compliance;
D O I
10.1159/000246185
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
In an ongoing study of Lamisil(R) in children, 21 patients have so far been enrolled and preliminary data are reported in this paper. Eighteen have tinea capitis and 1 has tinea corporis. So far, Trichophyton tonsurans has been identified in 17 and Trichophyton violaceum in 2. Lamisil has so far proved to be well tolerated, efficacious and cost-effective in a 2-week course in those children with a Trichophyton species. If Microsporum canis is isolated, a longer course is probably indicated. Lamisil has the distinct advantage of producing good results in a short time period, making patient compliance less of a problem.
引用
收藏
页码:43 / 44
页数:2
相关论文
共 50 条
  • [41] ORAL TERBINAFINE AND ERYTHEMA MULTIFORME
    TODD, P
    HALPERN, S
    MUNRO, DD
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1995, 20 (03) : 247 - 248
  • [42] Effect of Lamisil(R) and azole antifungals in experimental nail infection
    Richardson, MD
    DERMATOLOGY, 1997, 194 : 27 - 31
  • [43] Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US
    Lauren Van Duyn Graham
    Elewski, Boni E.
    MYCOSES, 2011, 54 (06) : E679 - E685
  • [44] A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil®) with fluconazole (Diflucan®) in the treatment of onychomycosis
    Havu, V
    Heikkilä, H
    Kuokkanen, K
    Nuutinen, M
    Rantanen, T
    Saari, S
    Stubb, S
    Suhonen, R
    Turjanmaa, K
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (01) : 97 - 102
  • [45] A COMPARATIVE DOUBLE-BLIND-STUDY OF TERBINAFINE (LAMISIL) AND GRISEOFULVIN IN TINEA-CORPORIS AND TINEA-CRURIS
    HERNANZ, AD
    GOMEZ, SL
    LASTRA, FG
    PALANCAR, PM
    DIEZ, LI
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1990, 15 (03) : 210 - 216
  • [46] SUCCESSFUL 2-WEEK TREATMENT WITH TERBINAFINE (LAMISIL) FOR MOCCASIN TINEA-PEDIS AND TINEA-MANUUM
    WHITE, JE
    PERKINS, PJ
    EVANS, EGV
    BRITISH JOURNAL OF DERMATOLOGY, 1991, 125 (03) : 260 - 262
  • [47] Usefulness of 1% terbinafine HCl (Lamisil®) cream for hyperkeratotic-type tinea pedis and its transfer into the horny layer
    Tanuma, H
    Doi, M
    Ohta, Y
    Nishiyama, S
    Katsuoka, K
    Kaneko, S
    Mukai, H
    Abe, M
    MYCOSES, 2000, 43 (11-12) : 417 - 432
  • [48] LION-Study:: efficacy and tolerability of continuous terbinafine (Lamisil®) compared to intermittent itraconazole in the treatment of toenail onychomycosis
    Sigurgeirsson, B
    Billstein, S
    Rantanen, T
    Ruzicka, T
    Di Fonzo, E
    Vermeer, BJ
    Goodfield, MJD
    Evans, EGV
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 : 5 - 14
  • [49] A COMPARISON OF TERBINAFINE (LAMISIL(R)) 1-PERCENT CREAM GIVEN FOR ONE WEEK WITH CLOTRIMAZOLE (CANESTEN(R)) 1-PERCENT CREAM GIVEN FOR 4 WEEKS, IN THE TREATMENT OF TINEA-PEDIS
    EVANS, EGV
    BRITISH JOURNAL OF DERMATOLOGY, 1994, 130 : 12 - 14
  • [50] Isolated thrombocytopenia associated with oral terbinafine
    Tsai, HH
    Lee, WR
    Hu, CH
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (03) : 627 - 628